News

Filter

Current filters:

Prevacid NapraPAC

1 to 9 of 228 results

Takeda’s 3rd quarter profits hit by in-licensing costs and sales declines for Actos and Prevacid

04-02-2010

Japan’s largest drugmaker Takeda posted results for the nine months ended December 31, 2009, reporting…

ActosFinancialLansoprazolePharmaceuticalPioglitazonePrevacidPrevacid NapraPAC

Japanese drug majors deliver mixed first-half results

02-11-2009

Three of Japan’s largest drugmakers, number one Takeda and numbers three and four, Daiichi Sankyo…

ActosAriceptAsia-PacificDaiichi SankyodonepezilEisaiFinancialLansoprazolePharmaceuticalPioglitazonePrevacidPrevacid NapraPACRanbaxy LaboratoriesSankyo

Record sales balanced by costs for Takeda

27-05-2009

Takeda Pharmaceuticals' sales reached record highs during fiscal 2008, due to the firm's acquisition…

ActosLansoprazolePioglitazonePrevacidPrevacid NapraPACTakeda Pharma GmbHTakeda PharmaceuticalsTakeda Pharmaceuticals America

Novartis gets FDA approval for OTC Prevacid

15-05-2009

Novartis gains FDA approval of OTC Prevacid

Swiss drug major Novartis says that Prevacid 24HR (lansoprazole…

LansoprazoleNovartisPrevacidPrevacid NapraPACTakeda Pharma GmbHTakeda PharmaceuticalsTakeda Pharmaceuticals America

Takeda's profit falls 34% for fiscal 2008, on costs, and reduces 2009 guidance

12-05-2009

The largest pharmaceutical firm in Japan, Takeda Pharmaceutical, reported fiscal 2008 income that was…

Abbott LaboratoriesActosLansoprazolePioglitazonePrevacidPrevacid NapraPAC

1 to 9 of 228 results

Back to top